Northern Trust’s BioRestorative Therapies BRTX Stock Holding History

Northern Trust’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.03K	Buy	+1,200	New	+$7.02K	﹤0.01%	4418

Other funds holding BRTX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Northern Trust's BRTX Position: Q2 2026 in Review

Northern Trust opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 1,200 shares worth $9.03K. The stake represents ﹤0.01% of the portfolio and ranks #4418 among its holdings.

18 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

Northern Trust held 1,200 shares of BioRestorative Therapies worth $9.03K as of Q2 2026.
BioRestorative Therapies was a new Northern Trust position in Q2 2026.
BioRestorative Therapies made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4418 holding.
18 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.